Added to this, the phenotype of mice with a 25% reduction in CLDN-5 is predicted to be much weaker than that of mice with 50% reduction of CLDN-5 that have previously shown significant memory impairment while also showing a lowered threshold of kainic acid-induced epilepsy [17]. The gene discussed is CLDN5; the disease is epilepsy.